Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21921
Title: Prostate-specific membrane antigen for the surgical oncologist: interpreting expression beyond the prostate.
Austin Authors: Farag, Matthew ;Bolton, Damien M ;Lawrentschuk, Nathan
Affiliation: Department of Surgery, The University of Melbourne, Melbourne, Victoria, Australia
Department of Urology, Austin Health, Heidelberg, Victoria, Australia
Issue Date: May-2020
metadata.dc.date: 2019-10-16
Publication information: ANZ Journal of Surgery 2020; 90(5): 715-718
Abstract: The use of prostate-specific membrane antigen (PSMA) radiotracer in positron emission tomography (PET) has been successfully incorporated into the clinical management of prostate cancer. However, PSMA tracer uptake is not limited to prostate cancer tissue. We reviewed studies exploring PSMA expression beyond the prostate gland using techniques of 68 Ga-PSMA PET imaging and immunohistochemistry. PSMA expression has been associated with a variety of solid tumours, and the vasculature associated with neoplastic disease, suggesting that this trans-membrane glycoprotein may be involved in the neovascularisation process in malignancy. These studies demonstrate the need for more research into the potential utility for 68 Ga-PSMA PET imaging in patients with non-prostatic cancers.
URI: http://ahro.austin.org.au/austinjspui/handle/1/21921
DOI: 10.1111/ans.15479
ORCID: 0000-0003-3306-1531
0000-0002-5145-6783
0000-0001-8553-5618
PubMed URL: 31617674
Type: Journal Article
Subjects: PSMA
general surgery
surgical oncology
urology
Appears in Collections:Journal articles

Show full item record

Page view(s)

14
checked on Nov 25, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.